# AbbVie Inc. (ABBV) — Q3-2014 Earnings Results

**Report date:** 2014-10-31 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2014

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 3.73%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.89 | N/A | +14.84% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook regarding their earnings performance. They emphasized their commitment to future growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> The company remains focused on its long-term growth strategy.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report shows a solid performance with a notable EPS beat, which likely contributed to the stock's 3.73% increase. Investors may view this positive surprise as a sign of the company's resilience and potential for future growth, despite the lack of revenue details and guidance. The market's reaction suggests confidence in AbbVie's ongoing strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2014_